View all veterinary jobs
VetNurse.co.uk publishes a curated feed of veterinary nursing news for registered veterinary nurses (RVNs), students (SVNs) and veterinary nursing assistants, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest or professional significance — filtering out noise so busy veterinary nurses can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, referral and specialist settings, with a focus on issues affecting veterinary nurses in clinical and professional roles.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetNurse news by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
Reference
The ERP was established in 2016 when it emerged that an increasing number of research projects were being conducted in private veterinary practices. In these settings, researchers may not always be familiar with the regulations and the ethical best practice needed for clinical veterinary research.
The ERP reviews both prospective and retrospective research projects on cats, dogs, horses and farm animals. As well as reviewing animal-based research, the panel also reviews sociological studies involving veterinary staff.
There are currently seven available spaces on the panel, and the RCVS is looking to fill the spaces with:
The Panel is Chaired by Professor David Morton, who said: “I’ve been honoured to Chair the Ethics Review Panel for the last five years. Through my role as Chair, I have had the opportunity to work alongside some exceptional veterinary professionals and I encourage anyone with a keen interest in clinical veterinary research to apply for a position on the Panel.”
To apply, visit www.rcvs.org.uk/ethics-panel and send a completed application form and CV to ethics@rcvs.org.uk.
The deadline for applications is 5pm on Friday 16 July 2021.
Rowe Referrals, part of IVC Evidensia Referrals, was one of the very first practices to have an onsite MRI when it installed a 1.5T model five years ago. Now, thanks to investment from IVC Evidensia - of which it is a part - Rowe has been able to replace the ageing model with a new 3.0T machine, which will enable clinicians to diagnose and implement treatment plans quicker.
Referrals Manager at Rowe Referrals, Meg Hayman, said: "The difference between the two machines in amazing. The 1.5T produced very detailed scans but the 3.0T is incredible! It gives our clinicians the ability to perform more complex investigations with far greater clarity.
The practice says benefits will be seen across all disciplines, including neurology, internal medicine, ophthalmology, dentistry, orthopaedics and soft tissue.
Ian Jennings BSc BVSc CertVDI MRCVS RCVS Advanced Practitioner in Diagnostic Imaging said: "The new 3.0T MRI scanner allows us a much more detailed view of our patients, and has been especially useful for detection of smaller lesions in our neurological and orthopaedic cases. Specialised sequences can also be performed in less time, allowing us a greater ability to help more patients."
Across Europe, the company has over 30 technical experts who get over 2,500 technical calls each year about Cushing’s.
The company also publishes the Dechra Academy, which provides a range of free online courses for vet nurses.
There's also Dechra’s endocrinology app which was developed using data from the Royal Veterinary College’s VetCompass database to help vets diagnose and manage the endocrine disorders Addison’s disease (hypoadrenocorticism) and Cushing’s syndrome.
For owners, Dechra publishes the 'Suspecting Cushing’s' website and has created the Cushing’s monitoring app to help simplify the management process, improve compliance with medication and increase engagement in the dog’s care.
Sarah Musgrave, companion animal brand manager at Dechra, said: “Dechra has extensive experience in endocrinology.
"Cushing’s can be a challenge to identify, diagnose and manage and our ‘They’ve got Cushing’s. You’ve got us’ initiative demonstrates the comprehensive support that we have available for both vets and dog owners to help ensure that dogs with Cushing’s live long and healthy lives.”
https://www.dechra.co.uk/cushings-connect
The new law allows the Government to:
require that the owner travels with the pets, or within 5 days of the pets arriving.
Danny said: “As a vet, I've treated many dogs with cruelly cropped ears or docked tails, leaving them physically scarred and emotionally traumatised.
"Knowing this Bill will help us put a stop to this abuse and have a bigger impact on animal welfare than I could possibly have achieved in a lifetime treating individual animals, demonstrates how important this legislation will prove to be.
"Thanks to the support of organisations like the BVA and other animal welfare nonprofits, we got the Animal Welfare Bill through the Commons, through the Lords, and today passed into law."
The study analysed 321 canine cases reported to the VPS for electronic cigarette or e-liquid exposure, to assess the risk of nicotine toxicosis in dogs.
53% of dogs remained asymptomatic after oral exposure to e-liquid and 41% developed only mild signs.
Among the 47% that developed clinical signs, emesis, hypersalivation, and tachycardia were the most common.
Other potential signs of nicotine toxicity, such as tremor, ataxia, or tachypnoea, occurred in less than 7% of cases.
Clinical signs generally resolved within a few hours, with a median recovery time of 3 hours, varying from 10 minutes to 6 days.
28% of the dogs received no treatment or observation only, and 45% received gut decontamination, most commonly activated charcoal only or oral lavage only.
Two dogs required the removal of a foreign body (an electronic cigarette and an e-liquid refill bottle).
A moderate, severe or fatal outcome was reported in 6% of cases.
Two dogs died; one after chewing a bottle of e-liquid, and experiencing progressive tachypnoea, persistent tachycardia and hypotension, and one was euthanised due to financial constraints.
The severity of poisoning wasn’t related to the reported dose, and it’s not clear why large doses didn’t cause severe nicotine toxicosis.
The authors conclude that the majority of dogs exposed to e-liquids can be managed conservatively and treatment is symptomatic and supportive.
Nicola Bates, lead author of the study, said: “Although severe effects following exposure to e-cigarettes or e-liquid is uncommon in dogs, each case should be assessed on a case-by-case basis to determine if any decontamination or treatment is required”.
https://onlinelibrary.wiley.com/doi/10.1111/jsap.70014
The company now expects the vaccine will not be available until June 2025.
The company apologised for the disruption and inconvenience and says it will provide more information as soon as it becomes available.
For further information contact your Zoetis Account Manager or call Head Office on 0345 300 8034.
This year, there were over 41,000 nominations for the five awards which were set up 26 years ago to recognise the nation’s most outstanding veterinary professionals.
The other four winners were:
Vet of the Year: Claire Phillips, Wright & Moreton, Cheshire
Practice of the Year: Coastal Veterinary Group, King’s Lynn
Practice Support Staff of the Year: Hannah Reid, Westport Veterinary Clinic, South Queensferry
Practice Manager of the Year: Fiona Leathers, Westport Veterinary Clinic, South Queensferry
Joanna Maclennan, Director of Trading at Petplan said: “A highlight in our calendar, last night was an evening of celebration of the incredible work that goes on in veterinary practices on a daily basis."
The update includes a new scoring system of low, moderate or high cancer risk which replaces the original numerical HDI scores and simplifies interpretation for clinicians, making the screening process easier to communicate with pet owners.
HT Vista says the device can now categorise cancer risk levels, based on malignant probability, with a sensitivity of 90% and a negative predictive value (NPV) of 98%.
The company says this translates to a “low cancer risk” result having a malignant probability of 10% or less, allowing veterinary teams to rule out cancer of lumps and bumps without the need for invasive procedures.
The tool can also now provide alerts for some of the low-risk cases, identifying them as lipomas, sebaceus adenomas or benign epithelial masses.
Liron Levy-Hirsch DVM MRCVS, Managing Director at HT Vista, said: "I am incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system.
"Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumour types, we are taking another significant step forward.
"This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes.
"By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
On the other end of the scale, a “high cancer risk” result has a malignant probability of 50% or more and indicates a stronger likelihood of malignancy.
HT Vista says these cases require additional diagnostic tests for mass identification.
The company highlights a big distinction between this and other screening modalities is that it can be nurse-led.
HT Vista will be on display and there will be live demonstrations at BSAVA Congress from the 20th to the 22nd of March 2025.
https://bit.ly/ht-vista-screening-tool
The patient was a four-year-old Labrador called Vinny who, in 2019, became the first dog in the UK to receive a BioMedtrix canine ankle replacement system, implanted by Wear's Head of Orthopaedic Surgery, RCVS Specialist Neil Burton, assisted by Maciej Krukowski.
That first surgery, on Vinny’s right ankle, was successful. However, two years later he needed similar treatment to his left leg.
Neil said: “Vinny first presented to us at Wear Referrals in 2019 with hind limb lameness.
“He was diagnosed with osteoarthritis in his hock joints bilaterally due to a developmental condition called osteochondrosis of the talus causing him ongoing pain and lameness. We operated on the right ankle, with Vinny becoming the first dog in the UK to have this ankle replacement system placed.
“Vinny was significantly more comfortable on this limb postoperatively but his lameness progressively worsened in the left hind limb. The decision was made to perform the same surgery on the left ankle, making Vinny the first dog in the world to have this surgery performed bilaterally.
“Vinny has made another fine recovery from surgery and is now off medication, meaning he can exercise unrestricted and pain-free without a lifetime reliance on painkilling drugs.
“For our team at Wear to be able to offer him this pioneering surgery has been a great opportunity. He’s now a unique case, being both the first UK recipient of this BioMedtrix joint replacement as well as the world's first bilateral ankle replacement with the same system.”
For more information, visit www.wear-referrals.co.uk.
The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
https://chestergates.org.uk/referral-services.
The panel will present the latest information on the prevalence of this zoonotic disease, review prevention strategies, and highlight the significance of cystic echinococcosis in humans.
The panelists are:
Dr Carolyn Kyte MRCVS (pictured), Elanco's UK Technical Consultant said: “We are concerned about potential changes in the distribution of Echinococcus granulosus in the UK and a subsequent change in zoonotic risk.
"We are hoping this cross-disciplinary discussion will provide Congress and Expo attendees with the latest insights the profession needs to allow individual, risk-based parasite control in dogs.
"The responsible use of parasiticides needs a true One-Health collaborative approach.”
ESCCAP says that the risk of novel parasites and zoonoses spreading to new regions has risen alongside an increase in pet travel and changing climate conditions.
ESCCAP’s Guideline 09 offers detailed advice on how to protect dogs and cats that travel or are imported across European borders, minimise the risk of zoonotic transmission and prevent the establishment of new parasites in previously unaffected areas.
Topics covered in the guideline include:
The guideline emphasises the importance of early detection of parasitic infections by thorough clinical examinations, comprehensive travel history assessments and targeted diagnostic testing.
It also provides guidance on educating pet owners about zoonotic risks and implementing appropriate treatments and follow-up screenings.
www.esccap.org/guidelines/gl9/
The CertAVN was introduced in 2019 as a modular, more flexible postgraduate route for veterinary nurses, replacing the Diploma in Advanced Veterinary Nursing (DipAVN).
The RCVS says the update includes a new programme standard focused on creating a positive learning culture.
Julie Dugmore, RCVS director of veterinary nursing, said the standard is intended to ensure providers foster “inclusive, reflective and student-centred learning environments”, and that it strengthens expectations around academic support, how the qualification should advance knowledge, and the need for institutions to take student wellbeing into account.
For course providers, the changes signal clearer expectations not just around content and outcomes, but around the support structures and learning environment wrapped around the programme. For veterinary nurses considering the CertAVN, the framework highlights what providers are expected to put in place around academic support and student experience.
https://www.rcvs.org.uk/certavn
The scheme gives practices access to a dedicated website hosting short training films showing what to cover in a ten-minute consult for a range of common behaviour problems, alongside owner-facing leaflets and posters.
There's also a handy staff room poster with QR codes linking to the training films so team members can watch them on a coffee break, if they feel so inclined.
Behavet says that limited consultation time, patient insecurity, uncertainty over what advice to offer, and concerns about whether guidance is up to date or worthwhile all influence the level of behaviour support delivered in first-opinion practice.
The company argues this can create a vicious circle in which owners disengage, problems escalate, and specialist help is only sought once issues have become entrenched.
Behavet Impact aims to break that cycle by supporting earlier, more effective intervention.
To date, materials have already been delivered to more than 400 UK veterinary practices within the project’s first three months.
To join the initiative, contact Behavet: https://www.beha.vet
The report comes on the back of a survey by the association which found that 93% of vets say sustainability is important to them.
The BVA says the report aims to break down the challenge that both teams and individuals face in working towards net zero emissions.
It explains the impact of climate change, what the veterinary profession’s role is in tackling it and why the BVA thinks it is so important that the profession plays its part.
The report also includes resources and showcases the ways real veterinary workplaces are taking action to reduce their impact on the environment.
British Veterinary Association Senior Vice President Anna Judson said: “Many veterinary professionals have long been concerned about the impact the sector is having on the environment, and many are already taking action to mitigate this.
"However, there is still more work to do.
"Our vision is that by 2050 the profession will have adapted to support the UK’s net zero targets; is trusted on mitigating its own carbon footprint; and is a leading advocate for environmental sustainability.
"This new report is providing vet teams with the tools and the inspiration to do their bit, because small changes add-up to make a big difference.”
There'll be a session on the subject at the London Vet Show this year, chaired by Anna Judson, with panelists Ed Bailey, Clinical Director and Sustainability Lead at George Farm Vets, Laura Binnie, Sustainability Lead at Paragon Veterinary Group and James Bevan, Planetary Health Senior Teaching Fellow Public Health Registrar, University of Southampton.
"Practice what you preach: Reaching net zero is a team effort" will be held at 10.45am - 11.45am on 14 November in the BVA Congress Theatre.
www.bva.co.uk/net-zero-report
Jessica Dawe, Deputy Head Nurse of Nine Mile Veterinary Hospital, won the individual award.
Her nomination read: "Every day, she comes in with a smile and puts in 100%, no matter the challenges faced the day before.
"Jess does not give herself the credit she deserves, as she is an amazing veterinary nurse, colleague, manager and friend to everyone.
"Her resilience, modesty, knowledge and clinical skills are admirable and we would be lost without her, and therefore, Jess is very much the diamond in our practice.”
The team award was won by the nursing team at ChesterGates Veterinary Specialists.
The runners up were Claire Mortimore from Caerphilly Veterinary Clinic, and the team at York Vets for Pets
BVNA President Lyndsay Hughes said: “The entries we have received have inspired and energised us, and we hope it’s been a real boost to all those who have been nominated too.
"It was incredibly difficult to judge the entries and shortlist our deserving winners and runners up, and we’d like to thank everyone to took the time to nominate their VN “diamonds”.
“Thank you to everyone who participated and played their part during this year's VNAM, which was especially important to us in 2025 taking place during BVNA’s 60th year.
"Your continued efforts are crucial to raise further awareness of the incredible work that veterinary nurses do, along with the significant impact they have on animal welfare, and in supporting veterinary teams and their clients.”
The webinar is the first of several events which will focus attention on patients owned by the estimated 80% of owners who feel that their pets with canine osteoarthritis (OA) may be suffering from off-days that can be associated with breakthrough pain¹.
During the session, Matt will explain the impact breakthrough pain has on the pet and owner and how to approach it more effectively using analgesic and rehabilitation tools and strategies.
James Beaumont, Marketing Manager at Animalcare, said: “Veterinary surgeons have told us that they estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain.²
"Additionally, a proportion of pet owners state their dogs experience off-days and believe their pet suffers as a result of the condition³."
Animalcare says that some of the main factors in osteoarthritis breakthrough pain can include variable plasma drug levels between doses, intermittent treatment protocols or poor owner adherence with the vet’s recommendation, flare-ups and disease progression.
To register for the event, visit: https://tinyurl.com/43bm8mdx. All those who register will also be able to view a recording and enter a free prize draw for the chance to win tickets to attend London Vet Show live in November.
At the meeting, Simon Biles from Moore Scarrott gave a 30 minute presentation, which was followed by a one hour discussion.
The recording can be watched on VetNurse.co.uk here https://www.vetnurse.co.uk/001/nonclinical/m/meetings/156693, where you can also claim the time watching towards your annual CPD requirement. Press the 'Claim CPD' red button in the title bar towards the top.
To make it easier to find content that interests you, there are markers on the video timeline.
There is also a forum thread on vetsurgeon.org for further discussion of any of the points raised in the film. See: https://www.vetnurse.co.uk/001/nonclinical/f/vetnurse-site-support/32174/vetnurse-zoom-ir35-locums-umbrella-companies-and-corporates/177103#177103
For more information about Moore Scarrott, visit: https://www.moore-scarrott.co.uk
Winners of the 2008 Petplan Veterinary Awards, which recognise and applaud staff and practices for their outstanding excellence and service, will feature on Natasha Kaplinsky's Channel Five news slot from tonight at 5:00pm, and then again at 7:00pm.
Tonight's news will cover the story of the Veterinary Practice of the Year: Orwell Veterinary Group, and there'll be more coverage on Tuesday and Wednesday as follows:
Tuesday 13th May 5pm & 7pm - Vet of the Year - Brian Faulkner of the Melton Veterinary Surgery
Wednesday 14th May 5pm & 7pm - Vet Nurse of the Year - Louisa Baker of the Priors Leaze Veterinary Centre.
Should be great publicity for the profession, and it is difficult to achieve this sort of thing, so hats off to Petplan.
Containing 3% m/v Chlorhexidine, Pyoderm is designed to support the natural microbial balance of the skin whilst delivering gentle yet effective cleansing.
Along with the rest of Virbac's range of dermatological and everyday care shampoos, Pyoderm is presented in 250ml eco-friendly bottles which are made from 100% recycled plastic and recyclable packaging.
The shampoos themselves are also biodegradable.
https://uk.virbac.com/
The event will include empowering talks by Vet Empowered founders Katie Ford and Claire Grigson MsRCVS.
Expert guests include Aoife Smith, an ex-RVN and psychotherapist, Chloé Hannigan from VetYogi and Jo Kelly, a registered veterinary nurse and accredited nutritional therapist.
There'll be hands-on workshops and immersive activities aimed at challenging comfort zones, fostering connections, and cultivating a mindset of growth and empowerment.
The organisers say Vet Empowered Live also offers the chance to connect with like-minded professionals, share experiences, and build a supportive community of peers committed to personal and professional growth.
Katie said: "We're thrilled to bring Vet Empowered Live to life and provide veterinary professionals with a unique opportunity to invest in their personal development.
"Our mission is to empower individuals to unlock their full potential, overcome obstacles, and create fulfilling careers on their own terms.
"We are passionate about providing a safe and inspiring space to do this."
Tickets cost £150 and include six hours of CPD and food and drink throughout the day.
https://www.eventbrite.co.uk/e/vet-empowered-live-confidence-beyond-manchester-2024-tickets-775605325407
https://www.vetempowered.com
Anyone - clients, colleagues or mentors - can nominate a young vet who they think has exceptional clinical skills, a particular passion for equine welfare or great leadership skills.
To be eligible nominees need to be members of BEVA, have graduated within the past seven years and be a registered professional with the appropriate body (eg RCVS).
BEVA Council Member Gemma Dransfield said: “We all know that one superstar who's brilliant with patients, fantastic with clients, and just an all-round legend in the making."
“This is your chance to give them the recognition they deserve.
"The BEVA One To Watch Award recognises those who are shaping the future, setting new standards in equine care, and driving the next generation of equine veterinary excellence.
"Not only will they have the glowing accolade of winning, but they will also win some career-boosting perks.”
To put an individual forward for consideration, a seconder is needed and either the nominator or seconder must be a BEVA member.
All nominations will be reviewed by a panel of experts comprising a BEVA Careers Committee representative, a senior equine vet, a non-equine veterinary professional and an external industry representative or client.
Up to five finalists will be selected and invited for a friendly online chat with the judging panel.
The winner will be announced at BEVA Congress and will be presented with a trophy, one year of BEVA membership, a fully paid BEVA Congress experience (including a one-day pass, overnight stay, and ticket to the annual dinner) and an exclusive career-boosting opportunities with BEVA to help take their career to the next level.
All finalists will receive a one-day ticket to BEVA Congress.
www.beva.org.uk/About-us/What-we-do/BEVA-Awards/One-to-watch
The course, which starts on the 26th March 2026, will be delivered through the association's e-learning hub and combines small group face-to-face coaching, online learning and digital content.
The programme has been developed help both new leaders and those looking to strengthen their confidence, self-awareness, and practical leadership capabilities.
Topics include:
Pete Orpin, SPVS JVP and Course Facilitator said: “Veterinary leadership can be a daunting place, without appropriate support and training.
"Leaders do not automatically have all the answers.
"The course aims to provide delegates with peer-to-peer support and practical tools to take back to practice and implement.”
The course costs £2695+VAT for SPVS members and £3,465+VAT for non members.
Price includes one full day SPVS Congress delegate pass where the group will meet at the end of the course
https://spvs.org.uk/spvs-elevate